Case report {#sec1-1}
===========

A 66-year-old male with the history of prostate carcinoma, who underwent transurethral resection of the prostate 2 years back with raised PSA level and suspected spinal metastases, was referred for Ga-68-PSMA whole-body simultaneous PET/MRI scan for restaging. A bulky T2W hypointense mass was noted in residual prostate involving right seminal vesicle \[[Figure 1a](#F1){ref-type="fig"}\] with the base of the bladder and mesorectal fascia, showing diffusion restriction \[Figure [1b](#F1){ref-type="fig"} and [1c](#F1){ref-type="fig"}\], increased K^trans^ \[[Figure 1d](#F1){ref-type="fig"}\] and increased PSMA uptake SUV max = 12.1 to 21.1 \[Figure [1e](#F1){ref-type="fig"} and [1f](#F1){ref-type="fig"}\]. No enlarged/PSMA avid nodes were seen. Widespread PSMA avid marrow lesions were seen extensively involving the spine \[Figure [1g](#F1){ref-type="fig"} and [1h](#F1){ref-type="fig"}\] and the remaining skeleton with SUV max = 8.5 to 27.5 \[[Figure 1i](#F1){ref-type="fig"}\].

![Representative PET/MRI images of a bulky hypointense mass (a) axial T2 is noted in residual prostate showing diffusion restriction (b) DWI with b = 800 and (c) ADC, (d) increased K^trans^ and (e) increased PSMA uptake (f) fused PET/MRI. No enlarged/PSMA avid nodes were seen. Sagittal STIR (g) and fused PET/MRI (h) images showing PSMA avid marrow lesions. MIP PET (i) image showing wide spread PSMA avid metastases in the remaining skeleton.](IJNM-32-159-g001){#F1}

Further, an enlarged thyroid gland showing multiple nodules of varying intensity and sizes involving both lobes \[Figure [2a](#F2){ref-type="fig"}--[2c](#F2){ref-type="fig"}\] was observed with focal increased PSMA uptake \[Figure [2d](#F2){ref-type="fig"}--[2f](#F2){ref-type="fig"}\] on the left side with SUV max = 5.9. No enlarged/ PSMA avid nodes were seen in bilateral neck.

![Representative PET/MRI image of an enlarged thyroid gland showing multiple nodules (a-c) axial T1; T2 and sagittal STIR respectively and focal areas of PSMA uptake (d-f) axial PET; axial fused PET/MRI and sagittal fused PET/MRI respectively.](IJNM-32-159-g002){#F2}

USG-guided FNAC of thyroid was done which was reported as Hurthle cell neoplasm. Subsequently, total thyroidectomy was performed and the excised gland was sent for HPE which revealed multiple large nodules in both lobes consistent with Hurthle cell adenoma \[[Figure 3a](#F3){ref-type="fig"}\]. In addition, small sub centimeter foci showing tubule-papillary architecture of papillary carcinoma \[[Figure 3b](#F3){ref-type="fig"}\] were also noted in both lobes of thyroid. Subsequently, immunohistochemistry analysis was carried out and the thyroid lesions were found to show intense expression for thyroglobulin \[[Figure 3c](#F3){ref-type="fig"}\] and no expression for PSA \[[Figure 3d](#F3){ref-type="fig"}\] thereby ruling out metastases from PCa and proving that it is a primary thyroid neoplasm. A small pretracheal node sampled during surgery was reported to have metastases from papillary thyroid carcinoma based on its follicular architecture \[Figure [3e](#F3){ref-type="fig"} and [3f](#F3){ref-type="fig"}\]. The pretracheal node was positive for thyroglobulin and negative for PSA \[Figure [3g](#F3){ref-type="fig"} and [3h](#F3){ref-type="fig"}\]. Central compartment neck lymph nodes showed no evidence of metastases. There was no lymphovascular, perineural, capsular invasion and extension into the perithyroidal soft tissue associated with any of the tumors.

![Histopathological examination showed (a) multiple large nodules in both lobes consistent with Hurthle cell adenoma, 10X, comprising of microfollicles lined by cuboidal cells showing abundant deeply eosinophilic cytoplasm. (b) Sub centimeter foci showing tubule-papillary architecture of papillary carcinoma (10X). (c,d) Immunohistochemistry analysis in thyroid lesions showing intense expression for thyroglobulin (10X) and no expression for PSA (10X). (e,f) A small pretracheal metastatic node from papillary thyroid carcinoma (4X and 10X respectively). (g,h) The node showed positive expression for thyroglobulin (10X) and negative expression for PSA negative (4X).](IJNM-32-159-g003){#F3}

Discussion {#sec1-2}
==========

PSMA based simultaneous PET/MRI is a novel imaging technique which has been used in diagnosis of recurrent prostate carcinoma.\[[@ref1]\] PSMA uptake has been demonstrated in both non-prostatic neoplastic\[[@ref2][@ref3][@ref4][@ref5][@ref6]\] and non-neoplastic lesions.\[[@ref7][@ref8]\] PSMA uptake is also seen in both benign\[[@ref9]\] and malignant neoplasms of thyroid.\[[@ref10][@ref11][@ref12]\] Although rare, metastatic spread to the thyroid gland from primary PCa has been reported in the past.\[[@ref13][@ref14]\] In this patient, metastases to the thyroid was a distinct possibility in view of widespread metastatic disease not observed in this case. So, in a case of PSMA avid thyroid lesion, it is important to differentiate metastases with primary thyroid neoplasm with biopsy before initiating further treatment.
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